SG162615A1 - Bazedoxifene treatment regimens - Google Patents
Bazedoxifene treatment regimensInfo
- Publication number
- SG162615A1 SG162615A1 SG200608134-3A SG2006081343A SG162615A1 SG 162615 A1 SG162615 A1 SG 162615A1 SG 2006081343 A SG2006081343 A SG 2006081343A SG 162615 A1 SG162615 A1 SG 162615A1
- Authority
- SG
- Singapore
- Prior art keywords
- bazedoxifene
- treatment regimens
- dosing
- hypercholesteremia
- azepan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38859602P | 2002-06-13 | 2002-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG162615A1 true SG162615A1 (en) | 2010-07-29 |
Family
ID=29736501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200608134-3A SG162615A1 (en) | 2002-06-13 | 2003-06-13 | Bazedoxifene treatment regimens |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040063692A1 (no) |
EP (1) | EP1531807A4 (no) |
JP (1) | JP2005531613A (no) |
KR (1) | KR20050010886A (no) |
CN (1) | CN1658868A (no) |
AU (1) | AU2003248707A1 (no) |
BR (1) | BR0311774A (no) |
CA (1) | CA2489098A1 (no) |
CR (1) | CR7585A (no) |
EC (1) | ECSP045492A (no) |
IL (1) | IL165210A0 (no) |
MX (1) | MXPA04011634A (no) |
NI (1) | NI200400065A (no) |
NO (1) | NO20044954L (no) |
NZ (1) | NZ537051A (no) |
RU (1) | RU2355397C2 (no) |
SG (1) | SG162615A1 (no) |
UA (1) | UA85374C2 (no) |
WO (1) | WO2003105834A1 (no) |
ZA (1) | ZA200409991B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1703910A2 (en) * | 2004-01-13 | 2006-09-27 | Wyeth | Treatment of aromatase inhibitor therapy-related osteoporosis |
BRPI0509381A (pt) * | 2004-04-08 | 2007-09-18 | Wyeth Corp | dispersão sólida, métodos de preparar a dispersão sólida, de tratar um mamìfero tendo uma doença ou sìndrome associadas com a deficiência ou o excesso de estrogênio, uma doença ou distúrbio associados com a proliferação ou desenvolvimento anormal de tecidos endometrais, de tratar cáncer de mamas de um mamìfero, e uma mulher pós-menopáusica quanto a um ou mais distúrbios vasomotores, de reduzir colesterol, e de inibir perda óssea em um mamìfero, composição, forma de dosagem, e, uso de uma dispersão sólida |
EP1732888A1 (en) * | 2004-04-08 | 2006-12-20 | Wyeth | Bazedoxifene ascorbate as selective estrogen receptor modulator |
WO2006104791A1 (en) * | 2005-03-31 | 2006-10-05 | Wyeth | O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
PE20070188A1 (es) * | 2005-06-29 | 2007-03-16 | Wyeth Corp | Formulaciones de estrogenos conjugados y bazedoxifeno |
MX2008002484A (es) * | 2005-08-24 | 2008-04-07 | Wyeth Corp | Formulaciones de acetato de bazedoxifeno y proceso de fabricacion de los mismos. |
CL2007003429A1 (es) * | 2006-11-29 | 2008-04-11 | Wyeth Corp | Tableta bi-capa que comprende una primera capa con al menos un estrogeno y una segunda capa con uno o mas agentes terapeuticos seleccionados entre un modulador selectivo del receptor de estrogeno y un agente progestacional; proceso de produccion, uti |
ITMI20091109A1 (it) | 2009-06-23 | 2010-12-24 | Wyeth Corp | Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione |
WO2013182169A1 (en) * | 2012-06-07 | 2013-12-12 | Zentiva, K. S. | Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate |
KR101940569B1 (ko) * | 2017-05-24 | 2019-01-21 | 아주대학교산학협력단 | 바제독시펜 또는 이의 약학적으로 허용가능한 염을 포함하는 약학 조성물 |
CN112076163B (zh) * | 2019-06-14 | 2023-06-20 | 四川科伦药物研究院有限公司 | 一种醋酸巴多昔芬片的药物组合物及其制备方法 |
CN113244240A (zh) * | 2021-05-26 | 2021-08-13 | 深圳市人民医院 | 醋酸巴多昔芬在治疗急性髓系白血病药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998402A (en) * | 1996-04-19 | 1999-12-07 | American Home Products Corporation | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
WO2002003992A2 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for treating prosthesis-related bone degeneration |
WO2002003991A2 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for increasing nitric oxide synthase activity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW303299B (no) * | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
PT802183E (pt) * | 1996-04-19 | 2002-03-28 | American Home Prod | Agentes estrogenicos |
US6479535B1 (en) * | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
US6583170B1 (en) * | 1998-05-15 | 2003-06-24 | Wyeth | 2-Phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol and estrogen formulations |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
EP1192945A3 (en) * | 2000-09-21 | 2004-03-03 | Pfizer Products Inc. | Use of an estrogen agonist/antagonist for treating osteoarthritis |
-
2003
- 2003-06-13 KR KR10-2004-7020140A patent/KR20050010886A/ko not_active Application Discontinuation
- 2003-06-13 AU AU2003248707A patent/AU2003248707A1/en not_active Withdrawn
- 2003-06-13 EP EP03760414A patent/EP1531807A4/en not_active Withdrawn
- 2003-06-13 BR BRPI0311774-0A patent/BR0311774A/pt not_active IP Right Cessation
- 2003-06-13 MX MXPA04011634A patent/MXPA04011634A/es unknown
- 2003-06-13 SG SG200608134-3A patent/SG162615A1/en unknown
- 2003-06-13 CA CA002489098A patent/CA2489098A1/en not_active Abandoned
- 2003-06-13 CN CN03813425XA patent/CN1658868A/zh active Pending
- 2003-06-13 WO PCT/US2003/019011 patent/WO2003105834A1/en active Search and Examination
- 2003-06-13 RU RU2004136316/14A patent/RU2355397C2/ru not_active IP Right Cessation
- 2003-06-13 JP JP2004512738A patent/JP2005531613A/ja active Pending
- 2003-06-13 US US10/460,843 patent/US20040063692A1/en not_active Abandoned
- 2003-06-13 NZ NZ537051A patent/NZ537051A/en unknown
- 2003-06-13 UA UA20041210175A patent/UA85374C2/ru unknown
-
2004
- 2004-11-12 NO NO20044954A patent/NO20044954L/no not_active Application Discontinuation
- 2004-11-12 NI NI200400065A patent/NI200400065A/es unknown
- 2004-11-15 IL IL16521004A patent/IL165210A0/xx unknown
- 2004-11-24 CR CR7585A patent/CR7585A/es not_active Application Discontinuation
- 2004-12-09 ZA ZA200409991A patent/ZA200409991B/en unknown
- 2004-12-13 EC EC2004005492A patent/ECSP045492A/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998402A (en) * | 1996-04-19 | 1999-12-07 | American Home Products Corporation | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
WO2002003992A2 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for treating prosthesis-related bone degeneration |
WO2002003991A2 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for increasing nitric oxide synthase activity |
Also Published As
Publication number | Publication date |
---|---|
EP1531807A4 (en) | 2007-10-31 |
IL165210A0 (en) | 2005-12-18 |
JP2005531613A (ja) | 2005-10-20 |
UA85374C2 (en) | 2009-01-26 |
US20040063692A1 (en) | 2004-04-01 |
NZ537051A (en) | 2007-11-30 |
ECSP045492A (es) | 2005-03-10 |
KR20050010886A (ko) | 2005-01-28 |
MXPA04011634A (es) | 2005-07-05 |
ZA200409991B (en) | 2007-09-26 |
CA2489098A1 (en) | 2003-12-24 |
NI200400065A (es) | 2005-08-09 |
RU2004136316A (ru) | 2005-05-10 |
CN1658868A (zh) | 2005-08-24 |
BR0311774A (pt) | 2007-05-08 |
EP1531807A1 (en) | 2005-05-25 |
AU2003248707A1 (en) | 2003-12-31 |
NO20044954L (no) | 2004-12-16 |
WO2003105834A1 (en) | 2003-12-24 |
RU2355397C2 (ru) | 2009-05-20 |
CR7585A (es) | 2008-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG162615A1 (en) | Bazedoxifene treatment regimens | |
PL365283A1 (en) | Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h | |
ATE450508T1 (de) | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren | |
HUP9701694A3 (en) | Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds | |
NO20031266D0 (no) | Kondenserte heterocykliske suksinimid-forbindelser og analoger derav, modulatorer for nukle¶r hormonreseptorfunksjon | |
IS4819A (is) | Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar | |
EA199800797A1 (ru) | Новые мостиковые циклические аминокислоты как фармацевтически применимые вещества | |
PL367264A1 (en) | Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes | |
DK0918774T3 (da) | Androgenreceptormodulatorforbindelser og fremgangsmåder | |
HK1047580A1 (en) | Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes. | |
DK0800519T3 (da) | Steroidreceptormodulatorforbindelser og fremgangsmåder | |
ATE276245T1 (de) | Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis | |
NO20000521D0 (no) | 1-(N-fenylaminoalkyl)-piperazin derivater substituert i posisjon 2 på fenylringen | |
DE60309909D1 (de) | Glucocorticoidrezeptorliganden zur behandlung von stoffwechselstörungen | |
WO2004016256A3 (en) | AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION | |
YU2200A (sh) | Termodinamički stabilna modifikacija 1-(4-karbazoliloksi)-3-/2-(2-metoksifenoksi)etilamino/-2-propanola, postupak za njeno dobijanje i farmaceutske smeše koje je sadrže | |
IL147977A0 (en) | Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain | |
NO960332D0 (no) | Tbp2 fragmenter av transferrinreseptoren av neisseria meningitidis | |
DK1187832T3 (da) | Aminoheterocycler, som er anvendelige som farmaceutiske midler | |
PL337871A1 (en) | Application of a specific antagonist of the 5 ht2 receptor in production of a drug useful in treating the sleep apnoea | |
DK0946162T3 (da) | Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme | |
IL145645A0 (en) | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists | |
AU2003215190A8 (en) | Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. | |
DE69828998D1 (de) | Indolderivate verwendbar zur behandlung von u.a. osteoporosis | |
ZA95692B (en) | Neuroprotective compounds |